Maybe AI touches your deliverables. Maybe AI runs through the middle of how your company works. Either way, your pharma client's diligence questionnaire is already asking questions your sales deck cannot answer. Three hours to build the story, the evidence, and the judgment to walk into that conversation prepared instead of hopeful.
Get My Seat, $349$349 early bird through September 25, then $499. Live session, workbook, and your evidence register, started on your real offering.
Here is how providers lose pharma deals now, and it is rarely because the technology is weak. The buyer loses confidence because the provider cannot explain the intended use, the data, the evidence, or the human accountability behind their AI story. Sales says one thing, Product says another, Security says a third, and the diligence call exposes all three at once.
The questionnaires keep getting longer, and they are reaching everyone: companies selling AI products, and companies that simply use AI in how they deliver. If you have not seen the AI section yet, it is coming; getting ahead of it is the entire advantage.
A sponsor does not buy your model. They buy the ability to see: what your AI is for, what it must never do, what evidence stands behind each claim, and who is accountable when the answer is uncertain. Showing your work is not a defensive posture; it is the fastest trust-building move available to a provider, and the providers who master it make the buyer's job easier than their competitors do. "I do not know, and here is how I will find out" closes more deals than a perfect demo.
We can teach this from both chairs, because one of us spent a decade as the buyer, building the oversight rubrics your questionnaire descends from, and the other is a provider answering those questionnaires at top-20 pharma companies right now, this quarter.
What "approved" does and does not mean, how buyers translate your AI answers into risk tiers, and why the same claim needs different evidence depending on what your AI touches: a deliverable, a workflow, or a decision.
You start your minimum viable evidence register on your real offering, using the same AI-assisted build pattern we teach pharma teams, so the artifact and the skill arrive together. Then the green, amber, red claims guardrail that gets Sales, Product, and Security telling one story.
We walk a fictional provider through a full diligence exchange, question by question, with a former pharma buyer narrating what each answer does to her confidence, and you map every move onto your own claims. You leave knowing which of your answers are green today, and exactly what your 30-day evidence sprint looks like.
One of us wrote the questions. One of us is answering them right now. You get the buyer's real logic and the provider's live playbook in the same three hours, from two people who have sat on both sides of the table you are about to walk up to.
Founders, BD and sales leaders, product managers, security and privacy leads, quality leads, and delivery owners at CROs, agencies, data and AI companies, and consultancies that serve pharma. You belong here if AI touches what you deliver or how you deliver it, and you have a live pharma relationship or a serious plan to build one inside 12 months.
Not for you if: you have no target buyer yet (start with our free masterclass instead), or you want a lawyer's compliance opinion (we teach judgment and evidence, not legal advice).
| Seat | Through Sept 25 | From Sept 26 |
|---|---|---|
| Standard | $349 | $499 |
| Premium: the Private Review | $799 | $899 |
What Premium buys: a private session for your company alone, the week after: we review your actual evidence register and claims story with you, off the record, and pressure-test your answers before a real buyer does. Private on purpose; your diligence gaps are nobody else's business, least of all a competitor who might share the main room with you.
Every seat includes the live session, the workbook, and your started evidence register. We do not record the bootcamps. The work happens live, hands on keyboard, and that is the point. At checkout you can add our Advanced Community, the ongoing home for providers building AI maturity; optional, yours to skip.
Against a six-figure pharma deal, this is the cheapest rehearsal you will ever run.
There is no universal "approved for pharma" badge, and anyone selling you one is the reason diligence exists. We do not and cannot promise that deals stop stalling or that any buyer says yes; implementation is yours, and accountability for your claims stays with you, which is rather the point of the whole discipline. What we promise is the tools, the insider insight, and the rehearsal: bounded claims, inspectable evidence, and one consistent answer from every seat on your team.
One more insider note, free: sponsors have started asking providers not just whether they use AI, but how the efficiency shows up in rates and hours. The providers who can answer that question with a straight face and a clear story are having very different renewal conversations than the ones who cannot. That is the level this bootcamp is aimed at.
Need the justification for your leadership? Download the letter.
[PROOF PLACEHOLDER: attendee quotes after first delivery.]
Your next diligence conversation is coming either way. Walk in with your work ready to show.
Get My Seat, $349